UK Community Advisory Board (UK-CAB)

UK-CAB 10 – Introduction to statistics 3 – AIDS 2004 conference

13 August 2004

Bangkok feedback studies – Word document (404 Kb)

PowerPoint slides for the meeting
Statistics part three, Dr Caroline Sabin, Royal Free Hospital [312k]


08:45-09:00 Registration and coffee/tea
09:00–09:15 Introduction and welcome to the 10th UK CAB
09:30–11:00 Feedback report:

  • Bangkok conference
  • MTCT studies – Polly Clayden
  • Harm reduction and IDU studies – Carmen Tarrades
  • 3TC monotherapy, Kaletra monotherapy – Simon Collins
  • European cohort studies – Anna Poppa
11:00–11:30 Break
11:30–13.00 Introduction to statistics: part three – Dr Caroline Sabin, Royal Free Hospital
13:00–14:00 Lunch
14:00–15:00 Introduction to statistics: part three continued – Dr Caroline Sabin, Royal Free Hospital
15:00­–16:00 Bangkok conference feedback:

  • Access issues – Martin Leigh
  • Pharmocology and drug interactions – Polly Clayden
  • Any other feedback
16:00–16:30 Any other businessVaccine sub-group feedback

Glasgow conference, etc.

16:30 Meeting close

Financial support

The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.

The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.

We believe that manufacturers who currently develop and market medicines have a responsibility to actively engage with advocacy organisations and that HIV positive people and their advocates should be able to directly question manufacturers about the safety and efficacy of their products and proposals for future research.

For a list of companies that support the UK-CAB please see the “about us” page.

Link to top of page